QUITTER: Dual-Wrist Wearable - The Cost of Commitment

Traditional nicotine replacement therapies (NRTs) and counseling consistently face high failure rates because they rely on fragile human willpower. QUITTER disrupts the cessation landscape by introducing a revolutionary "Commitment-as-a-Service" digital therapeutic ecosystem, bridging behavioral economics with clinical-grade biometric monitoring to enforce patient adherence.
The intervention begins with an algorithm that assesses the user's nicotine dependency, prescribing a tailored 30-to-60-day cessation cycle. To activate this treatment, users must lock a substantial financial deposit, utilizing the psychological principle of "Loss Aversion" to outsource their discipline to an uncompromising system.
To ensure absolute clinical compliance, QUITTER employs dual-wrist wearables equipped with 6-axis IMUs and medical-grade PPG sensors. The system executes "Precision Dual-Sensing," cross-referencing the specific kinematics of smoking gestures with nicotine-induced heart rate spikes. This provides irrefutable biometric evidence of a relapse, eliminating false positives. A sealed, non-rechargeable 60-day battery eradicates monitoring blind spots, guaranteeing 24/7 unbroken accountability.
QUITTER operates on a highly scalable "Win-Win" public health paradigm. Successful completion allows users to reclaim their physiological autonomy and their full deposit. Conversely, a detected relapse triggers an instant forfeiture of the funds to tobacco-cessation non-profits. QUITTER elevates addiction treatment from an isolated personal struggle into a self-sustaining funding mechanism for global public health, while ensuring environmental integrity through a closed-loop hardware recycling program.